BCM
Bayesian Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Buy |
+1,380
| New | +$418K | 0.07% | 324 |
|
|
2025
Q1 | – | Sell |
-3,573
| Closed | -$1.1M | – | 817 |
|
|
2024
Q4 | $1.1M | Buy |
3,573
+2,071
| +138% | +$639K | 0.13% | 217 |
|
|
2024
Q3 | $319K | Sell |
1,502
-1,907
| -56% | -$405K | 0.04% | 465 |
|
|
2024
Q2 | $955K | Buy |
+3,409
| New | +$955K | 0.11% | 244 |
|
|
2023
Q3 | – | Sell |
-5,860
| Closed | -$1.35M | – | 864 |
|
|
2023
Q2 | $1.35M | Buy |
+5,860
| New | +$1.35M | 0.15% | 190 |
|
|
2023
Q1 | – | Sell |
-2,350
| Closed | -$682K | – | 972 |
|
|
2022
Q4 | $682K | Buy |
+2,350
| New | +$682K | 0.1% | 274 |
|